FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.